Search
-
-
-
Although there are a number of symptoms of multiple myeloma, about 1 out of every 3 people diagnosed with this cancer have no symptoms. Learn more about possible signs.
… One of the common early symptoms of multiple myeloma is bone pain. The disease can affect the bones in your spine and ribs, causing backaches. You may also get shooting pain in your arms or legs caused by a tumor in your spine. Not everyone who has multiple myeloma has symptoms. Most people develop symptoms
-
Video
In this student seminar from 12/08/20, Dr. Ross Levine discusses fundamentals of cancer biology, including the scientific process of developing targeted therapies.
… Speaker: Ross Levine, MD, Laurence Dineen Chair in Leukemia Research; Chief, Molecular Cancer Medicine Service, MSK Human Oncology and Pathogenesis Program (HOPP)
-
The Dirk Remus Lab
… Job Title Postdoctoral Associate Degree PhD Email [email protected] Lab Phone 212-639-5264
-
News
A surprising discovery linking the hormone insulin to skin pigmentation offers fresh insights into how animal bodies take shape.
… Thursday, May 24, 2018 Summary Scientists at the Sloan Kettering Institute have made a surprising find about how the hormone insulin contributes to skin pigmentation in fish. The discovery may have implications for human cancer. If you’re a zebra, you want your stripes in order. Come to the savannah
-
The Antitumor Assessment Core provides resources, professional and technical expertise, and advisory services related to the evaluation of a wide range of agents with potential antitumor activity.
… The Antitumor Assessment (ATA) Core provides support for early discovery and in vivo testing of antitumor detection and therapeutic agents. The Core provides resources, professional and technical expertise, and advisory services related to the evaluation of agents with potential diagnostic or therapeutic
-
-
… December 10, 2001 Warning available at: http://www.fda.gov/Food/DietarySupplements/Alerts/default.htm LipoKinetix (Syntrax Innovations,Inc.) is a weight loss supplement that has been implicated as the cause of liver damage in six cases reported to the FDA. The product contains a combination of phenylpropanolamine
-
… Hedvig Hricak, MD, PhD Chair, Department of Radiology Carroll and Milton Petrie Chair Steven M. Larson, MD Chief, Nuclear Medicine Service Acting Chief, Radiopharmaceutical Chemistry Service Ronald Blasberg, MD Neuro-Oncology Lab Department of Neurology John Humm, PhD Chief, Nuclear Imaging Physics Department